Pyrotinib in Combination With Letrozole in Patients With HER2-Positive, ER-Positive Metastatic Breast Cancer

Condition:   Metastatic Breast Cancer Intervention:   Drug: Pyrotinib Maleate plus Letrozole Sponsors:   Hunan Cancer Hospital;   Jiangsu HengRui Medicine Co., Ltd. Recruiting

Source: ClinicalTrials.gov - May 29, 2020 Category: Research Source Type: clinical trials